US 12,403,251 B2
Device and method for making aseptic connections
Ian B. Hanson, Wayne, PA (US); Lawton Laurence, Phoenixville, PA (US); Antonio Ubach, Tucson, AZ (US); Rajan Ramaswamy, San Diego, CA (US); Daniel S. Codd, Escondido, CA (US); Scott Beaver, San Marcos, CA (US); Kevin L. Bokelman, San Diego, CA (US); Danielle Feldman, Philadelphia, PA (US); and Matthew J. Clemente, Carmel, IN (US)
Assigned to AMGEN INC., Thousand Oaks, CA (US)
Filed by AMGEN INC., Thousand Oaks, CA (US)
Filed on Jan. 24, 2020, as Appl. No. 16/752,075.
Application 16/752,075 is a continuation of application No. 15/552,828, granted, now 10,569,014, previously published as PCT/US2016/020486, filed on Mar. 2, 2016.
Claims priority of provisional application 62/148,082, filed on Apr. 15, 2015.
Claims priority of provisional application 62/127,021, filed on Mar. 2, 2015.
Prior Publication US 2020/0155759 A1, May 21, 2020
Int. Cl. A61M 5/162 (2006.01); A61J 1/20 (2006.01); A61M 5/14 (2006.01); A61M 5/142 (2006.01); A61M 5/145 (2006.01); A61M 5/158 (2006.01); A61M 39/18 (2006.01); A61J 1/14 (2023.01); A61M 5/24 (2006.01); A61M 5/32 (2006.01); A61M 5/34 (2006.01)
CPC A61M 5/162 (2013.01) [A61J 1/201 (2015.05); A61J 1/2051 (2015.05); A61M 5/1413 (2013.01); A61M 5/142 (2013.01); A61M 5/14248 (2013.01); A61M 5/1456 (2013.01); A61M 5/158 (2013.01); A61M 5/1626 (2013.01); A61M 39/18 (2013.01); A61J 1/1406 (2013.01); A61M 2005/14252 (2013.01); A61M 2005/1585 (2013.01); A61M 2005/2474 (2013.01); A61M 5/32 (2013.01); A61M 2005/341 (2013.01); A61M 2205/0216 (2013.01); A61M 2205/18 (2013.01); A61M 2205/581 (2013.01); A61M 2205/587 (2013.01)] 27 Claims
OG exemplary drawing
 
1. A drug delivery device comprising:
a drug container having a longitudinal axis and a distal end with an opening covered by a pierceable seal;
a connection hub having a rigid wall, the rigid wall having a drug container facing surface and a radially inwardly facing surface, the radially inwardly facing surface being closer to the pierceable seal than the drug container facing surface, the radially inwardly facing surface at least partially defining an interior space, wherein the rigid wall and any component of the drug delivery device formed in one piece with the rigid wall is free from contact with a distalmost surface of the pierceable seal and any component of the drug delivery device contacting the distalmost surface of the pierceable seal; and
a piercing member having an unactuated position wherein a tip of the piercing member is exterior to the drug container, and a delivery position wherein the tip of the piercing member pierces through the pierceable seal into the drug container,
wherein the tip of the piercing member is configured to move through the interior space of the connection hub in moving from the unactuated position to the delivery position, and the piercing member is free from contact with the pierceable seal and any member disposed at least partially within the pierceable seal when the piercing member is in the unactuated positioned.